Zhu et al. [30] performed a meta-analysis to explore the relationship between the ERCC5/XPG Asp1104His polymorphism and cancer risk under the recessive genetic model, and found null association between the polymorphism and the risk of CRC. The gene discussed is ERCC5; the disease is cancer.